Last updated on November 2017

An outpatient study is testing an investigational weight loss device intended to allow safe and effective weight loss and improvement of glycemic control


Brief description of study

An outpatient study is testing an investigational weight loss device intended to allow safe and effective weight loss and improvement of glycemic control

Detailed Study Description

Have you been diagnosed with Prediabetes or Type II Diabetes?

Are you treating your condition with diet or metformin alone?

A clinical research study is being conducted by Dr. John E. Ervin at The Center for Pharmaceutical Research. The outpatient study is testing an investigational weight loss device intended to allow safe and effective weight loss and improvement of glycemic control.

Clinical Study Identifier: TX10249

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Enrollment Services

The Center for Pharmaceutical Research
Kansas City, MO USA
  Connect »